Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Jaya Trishindo Tbk. (HELI) vs Organon Pharma Indonesia Tbk. (SCPI)

Jaya Trishindo Tbk.Trading
Organon Pharma Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Jaya Trishindo Tbk. dan Organon Pharma Indonesia Tbk.: Jaya Trishindo Tbk. diperdagangkan di Rp202 (kapitalisasi pasar 169,9 M, volume 24 jam 498,1 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Jaya Trishindo Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.

HELISCPI
Kapitalisasi Pasar
169,9 M104,4 M
Volume
498,1 rb
Lot
4,98 rb
Perputaran
100,81 jt
Harga Rata-rata
202,38
Nilai Transaksi
100,81 jt
Harga Ekuilibrium Indikatif
208
Volume Ekuilibrium Indikatif
10

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

HELI
Lihat detail
SCPI
Lihat detail

Tentang Jaya Trishindo Tbk.

PT Jaya Trishindo Tbk (the Company) was established based on Notarial Deed No. 19, which was amended by Deed No. 17 dated January 18, 2008 of Elizabeth Widyawati Santosa, S.H., notary in Bogor.

Selengkapnya di halaman HELI

Tentang Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Selengkapnya di halaman SCPI